HWKN

• Yi "Faith" Tang notified Hawkins, Inc. of her resignation from the Board of Directors and its committees on August 13, 2026.
• The resignation is not due to any disagreement with the company's operations, policies, or practices.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

• Shareholders ratified the appointment of Deloitte & Touche LLP as independent auditor for fiscal year ending March 28, 2027, with 18,091,616 votes for and 106,215 against.
• The non-binding advisory say-on-pay proposal was approved with 15,626,644 votes for, 450,896 against, and 15,963 abstentions.
• Broker non-votes were 2,143,592 for each director election and the say-on-pay proposal, and none for the auditor ratification.
• The report was filed under Item 5.07 to disclose the results of these shareholder votes.

5.07 Submission of Matters to a Vote of Security Holders

• Record first quarter revenue of $315.7 million, up 8% from $293.3 million in the prior-year quarter.
• Record adjusted EBITDA of $56.9 million, up 1% from $56.1 million.
• Acquired Aqua-Chem, Inc., a water treatment distributor in Nebraska and Iowa, for $3.6 million.
• Company expects full-year effective tax rate of approximately 25% to 27%.

2.02 Results of Operations and Financial Condition

• On May 13, 2026, Shirley A. Rozeboom, Vice President – Stauber, was determined to no longer be an executive officer of Hawkins, Inc., effective the same date.
• Ms. Rozeboom remains employed with the Company.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

• Fourth quarter diluted EPS was $0.74, down 5% from $0.78, due to increased amortization, interest, and earnout accretion from acquisitions.
• Full-year sales were $1,083.7 million, up 11% from $974.4 million, and gross profit was $245.1 million, up 9%.
• Full-year diluted EPS was $3.91, down 3% from $4.03, while adjusted EBITDA rose 6% to $179.0 million.
• For fiscal 2027, the company expects revenue and operating income growth in each segment, EPS growth, and a leverage ratio of approximately 1x adjusted EBITDA by year-end.

2.02 Results of Operations and Financial Condition

• Diluted EPS decreased 4% to $0.69 from $0.72, impacted by higher amortization and interest from acquisitions.
• Adjusted EBITDA rose 3% to $34.8 million, with trailing 12-month adjusted EBITDA of $179 million.
• Water Treatment segment sales grew 21% to $120.5 million, while Food & Health Sciences sales fell 10% to $70.0 million.
• Company expects WaterSurplus acquisition to be accretive in fiscal 2027 and anticipates returning to historical organic growth rates in fiscal 2027.

2.02 Results of Operations and Financial Condition

• Erstad is expected to cease serving as an executive officer effective December 28, 2025, the end of the company's third fiscal quarter.
• He is expected to remain employed by Hawkins, Inc. until May 2026 to ensure a smooth transition.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

• Diluted EPS was $1.08, down 7% from $1.16, due to a $5 million increase in amortization and interest expense from acquisitions.
• Adjusted EBITDA was $50.4 million, up 9% from $46.3 million; trailing 12-month adjusted EBITDA exceeded $178 million.
• Water Treatment segment sales grew 21% to $150.9 million; Industrial Solutions grew 11% to $56.6 million; Food & Health Sciences grew 2% to $72.9 million.
• Company expects Water Treatment and Industrial Solutions to grow in the second half, with Food & Health Sciences flat to down; WaterSurplus acquisition expected to be accretive in fiscal 2027.

2.02 Results of Operations and Financial Condition